LEXINGTON, Massachusetts,
April 25, 2017 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Jeff Poulton, Chief Financial Officer, will
participate at the Deutsche Bank 42nd annual health care
conference, at the InterContinental Boston Hotel on Thursday, May 4, 2017 at 10:40 AM EDT (15:40
BST).
A live audio webcast will be available on the Presentations and
Webcasts section of Shire's Investor website at
http://investors.shire.com/presentations-and-webcasts/.
Subsequently, a replay of the webcast will be available on this
same website for approximately 90 days.
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on
serving people with rare diseases and other highly specialized
conditions. We strive to develop best-in-class products, many of
which are available in more than 100 countries, across core
therapeutic areas including Hematology, Immunology, Neuroscience,
Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal /
Internal Medicine / Endocrine and Hereditary Angioedema; and a
growing franchise in Oncology.
Our employees come to work every day with a shared mission: to
develop and deliver breakthrough therapies for the hundreds of
millions of people in the world affected by rare diseases and other
high-need conditions, and who lack effective therapies to live
their lives to the fullest.
http://www.shire.com
For further information please contact:
Investor Relations
Ian Karp
ikarp@shire.com
+1-781-482-9018
Robert Coates
rcoates@shire.com
+44-1256-894874
SOURCE Shire plc